FR2949468B1 - Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique - Google Patents

Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique

Info

Publication number
FR2949468B1
FR2949468B1 FR0904091A FR0904091A FR2949468B1 FR 2949468 B1 FR2949468 B1 FR 2949468B1 FR 0904091 A FR0904091 A FR 0904091A FR 0904091 A FR0904091 A FR 0904091A FR 2949468 B1 FR2949468 B1 FR 2949468B1
Authority
FR
France
Prior art keywords
pyrazol
pyridin
derivatives
preparation
therapeutic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0904091A
Other languages
English (en)
Other versions
FR2949468A1 (fr
Inventor
Jean Michel Altenburger
Valerie Fossey
Stephane Illiano
Geraldine Manette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0904091A priority Critical patent/FR2949468B1/fr
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Priority to MYPI2011003011A priority patent/MY155244A/en
Priority to AU2009334570A priority patent/AU2009334570B2/en
Priority to SI200931025T priority patent/SI2382215T1/sl
Priority to PE2011001291A priority patent/PE20120338A1/es
Priority to NZ593797A priority patent/NZ593797A/xx
Priority to PL09805790T priority patent/PL2382215T3/pl
Priority to EP09805790.4A priority patent/EP2382215B1/fr
Priority to PT98057904T priority patent/PT2382215E/pt
Priority to EA201170900A priority patent/EA019774B1/ru
Priority to CA2748413A priority patent/CA2748413A1/fr
Priority to MX2011007061A priority patent/MX2011007061A/es
Priority to DK09805790.4T priority patent/DK2382215T3/da
Priority to PCT/FR2009/052692 priority patent/WO2010076525A1/fr
Priority to MA34029A priority patent/MA32978B1/fr
Priority to JP2011542887A priority patent/JP5865704B2/ja
Priority to BRPI0923875-1A priority patent/BRPI0923875A2/pt
Priority to SG2011047529A priority patent/SG172422A1/en
Priority to CN200980157589.3A priority patent/CN102333776B/zh
Priority to KR1020117017677A priority patent/KR101630475B1/ko
Priority to ES09805790.4T priority patent/ES2511917T3/es
Priority to TW098145333A priority patent/TWI441828B/zh
Priority to PA20098856101A priority patent/PA8856101A1/es
Priority to ARP090105127A priority patent/AR074916A1/es
Publication of FR2949468A1 publication Critical patent/FR2949468A1/fr
Priority to TN2011000308A priority patent/TN2011000308A1/fr
Priority to CR20110360A priority patent/CR20110360A/es
Priority to EC2011011164A priority patent/ECSP11011164A/es
Priority to IL213790A priority patent/IL213790A/en
Priority to NI201100132A priority patent/NI201100132A/es
Priority to ZA2011/04785A priority patent/ZA201104785B/en
Priority to CO11081313A priority patent/CO6400145A2/es
Priority to US13/172,321 priority patent/US8697731B2/en
Application granted granted Critical
Publication of FR2949468B1 publication Critical patent/FR2949468B1/fr
Priority to HK12104300.3A priority patent/HK1163679A1/xx
Priority to US14/200,698 priority patent/US9359329B2/en
Priority to CY20141100849T priority patent/CY1115635T1/el
Priority to SM201400157T priority patent/SMT201400157B/xx
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0904091A 2008-12-29 2009-08-28 Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique Expired - Fee Related FR2949468B1 (fr)

Priority Applications (36)

Application Number Priority Date Filing Date Title
FR0904091A FR2949468B1 (fr) 2009-08-28 2009-08-28 Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique
MA34029A MA32978B1 (fr) 2008-12-29 2009-12-24 Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique
SI200931025T SI2382215T1 (sl) 2008-12-29 2009-12-24 Derivati 2-piridin-2-il-pirazol-3(2H)-ona, njihova priprava in njihova terapevtska uporaba
PE2011001291A PE20120338A1 (es) 2008-12-29 2009-12-24 Derivados de 2-piridin-2-il-pirazol-3(2h)-ona, su preparacion y su aplicacion en terapeutica
NZ593797A NZ593797A (en) 2008-12-29 2009-12-24 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
PL09805790T PL2382215T3 (pl) 2008-12-29 2009-12-24 Pochodne 2-pirydyny-2-ylo-pirazol-3(2H)-onu, ich wytwarzanie i zastosowanie terapeutyczne
KR1020117017677A KR101630475B1 (ko) 2008-12-29 2009-12-24 ２-피리딘-２-일-피라졸-３（２ｈ）-온의 유도체, 그의 제조법 및 치료 용도
PT98057904T PT2382215E (pt) 2008-12-29 2009-12-24 Derivados de 2-piridin-2-il-pirazol-3(2h)-ona, sua preparação e sua aplicação terapêutica
EA201170900A EA019774B1 (ru) 2008-12-29 2009-12-24 Производные 2-пиридин-2-ил-пиразол-3(2h)-она, их получение и применение в терапии
CA2748413A CA2748413A1 (fr) 2008-12-29 2009-12-24 Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique
MX2011007061A MX2011007061A (es) 2008-12-29 2009-12-24 Derivados de 2 piridin- 2-il-pirazol-3 (2h)-ona, su preparacion y aplicacion terapeutica.
DK09805790.4T DK2382215T3 (da) 2008-12-29 2009-12-24 Derivater af 2-pyridin-2-yl-pyrazol-3(2h)-on, fremstilling og terapeutisk anvendelse heraf
PCT/FR2009/052692 WO2010076525A1 (fr) 2008-12-29 2009-12-24 Dérivés de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur préparation et leur application en thérapeutique
AU2009334570A AU2009334570B2 (en) 2008-12-29 2009-12-24 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
JP2011542887A JP5865704B2 (ja) 2008-12-29 2009-12-24 ２−ピリジン−２−イル−ピラゾール−３（２ｈ）−オンの誘導体、この調製および治療的使用
BRPI0923875-1A BRPI0923875A2 (pt) 2008-12-29 2009-12-24 Derivados de 2-piridin-2-il-pirazol-3 (2h)-ona, o respectivo preparo e a respectiva aplicação terapêutica.
SG2011047529A SG172422A1 (en) 2008-12-29 2009-12-24 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
EP09805790.4A EP2382215B1 (fr) 2008-12-29 2009-12-24 Dérivés de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur préparation et leur application en thérapeutique
MYPI2011003011A MY155244A (en) 2008-12-29 2009-12-24 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
ES09805790.4T ES2511917T3 (es) 2008-12-29 2009-12-24 Derivados de 2-piridin-2-il-pirazol-3(2H)-ona, su preparación y su aplicación en terapéutica
CN200980157589.3A CN102333776B (zh) 2008-12-29 2009-12-24 2-吡啶-2-基-吡唑-3(2h)-酮的衍生物、其制备和治疗用途
TW098145333A TWI441828B (zh) 2008-12-29 2009-12-28 ２－吡啶－２－基－吡唑－３（２ｈ）－酮衍生物、其製備及治療用途
PA20098856101A PA8856101A1 (es) 2008-12-29 2009-12-28 Derivados de 2-piridin-2-il-pirazol-3(2h)-ona, su preparcion y su aplicacion en terapeutica
ARP090105127A AR074916A1 (es) 2008-12-29 2009-12-28 Derivados de 2-piridin-2-il-pirazol-3(2h)-ona, su preparacion, composiciones farmaceuticas y su uso en enfermedades cardiovasculares.
TN2011000308A TN2011000308A1 (fr) 2008-12-29 2011-06-17 Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique
CR20110360A CR20110360A (es) 2008-12-29 2011-06-23 Derivados de 2-piridin-2-il-pirazol-3-(2h)-ona, su preparacion y su aplicacion en terapeutica
EC2011011164A ECSP11011164A (es) 2008-12-29 2011-06-27 Derivados de 2-piridin-2-il-pirazol-3(2h)-ona, su preparación y su aplicación en terapéutica
IL213790A IL213790A (en) 2008-12-29 2011-06-27 2-Pyridine-2-Ill-Pyrazole-3 (2 h) History - On, Preparation and Medical Use
NI201100132A NI201100132A (es) 2008-12-29 2011-06-28 Derivados de 2 - piridin - 2 - il - pirazol - 3 (2h) - ona, su preparación y su aplicación en terapéutica.
ZA2011/04785A ZA201104785B (en) 2008-12-29 2011-06-28 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one,preparation and therapeutic use thereof
CO11081313A CO6400145A2 (es) 2008-12-29 2011-06-29 Derivados de 2-piridin-2-il pirazol-3(2h) -ona, su preparción y su aplicación terapeútica
US13/172,321 US8697731B2 (en) 2008-12-29 2011-06-29 Derivatives of 2-pyridin-2-yl-pyrazol-3(2H)-one, preparation and therapeutic use thereof
HK12104300.3A HK1163679A1 (en) 2008-12-29 2012-05-02 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof 2--2---3(2h)-
US14/200,698 US9359329B2 (en) 2008-12-29 2014-03-07 Derivatives of 2-pyridin-2-yl-pyrazol-3(2H)-one, preparation and therapeutic use thereof
CY20141100849T CY1115635T1 (el) 2008-12-29 2014-10-16 Παραγωγα 2-πυριδιν-2-υλο-πυραζολ-3(2η)-ονης, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη
SM201400157T SMT201400157B (it) 2008-12-29 2014-10-29 Derivati di 2-piridin-2-il-pirazol-3(2H)-one, loropreparazione e loro uso terapeutico

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0904091A FR2949468B1 (fr) 2009-08-28 2009-08-28 Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2949468A1 FR2949468A1 (fr) 2011-03-04
FR2949468B1 true FR2949468B1 (fr) 2011-09-30

Family

ID=41820704

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0904091A Expired - Fee Related FR2949468B1 (fr) 2008-12-29 2009-08-28 Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique

Country Status (1)

Country Link
FR (1) FR2949468B1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750088A (en) * 1993-03-30 1998-05-12 The Dupont Merck Pharmaceutical Company Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
EP2074128B1 (fr) * 2006-10-16 2013-08-14 Medicis Pharmaceutical Corporation Pyrazolyl thienopyridines therapeutiques
WO2008137060A1 (fr) * 2007-05-04 2008-11-13 Amgen Inc. Dérivés de la thienopyridine et de la thiazolopyridine qui inhibent l'activité prolyle hydroxylase

Also Published As

Publication number Publication date
FR2949468A1 (fr) 2011-03-04

Similar Documents

Publication Publication Date Title
FR2949470B1 (fr) Derives anticancereux, leur preparation et leur application therapeutique
FR2945534B1 (fr) DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2953520B1 (fr) Derives de diphenyl-pyrazolopyridines, leur preparation et leur application en therapeutique
FR2933700B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
FR2915198B1 (fr) Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
FR2963007B1 (fr) Derives anticancereux, leur preparation et leur application therapeutique
FR2952934B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
FR2943669B1 (fr) Derives de nicotinamide,leur preparation et leur application en therapeutique
FR2915199B1 (fr) Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
FR2941696B1 (fr) Derives d'azaspiranyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique
FR2948939B1 (fr) Derives de 2h pyridazin-3-ones, leur preparation et leur application en therapeutique humaine
FR2945533B1 (fr) Derives de cyclopenta°c!pyrrolyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique
IL213790A (en) 2-Pyridine-2-Ill-Pyrazole-3 (2 h) History - On, Preparation and Medical Use
FR2917413B1 (fr) Derives de 7-alkynyl-1,8-naphthyridones, leur preparation et leur application en therapeutique
FR2927625B1 (fr) Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
FR2947546B1 (fr) Derives de pyrazoles, leur preparation et leur application en therapeutique
FR2940284B1 (fr) Derives de 6-cycloamino-2,3-di-pyridinyl-imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique
FR2963005B1 (fr) Derives d'oxadiazoles et de pyridazines, leur preparation et leur application en therapeutique
FR2925901B1 (fr) DERIVES DE N-HETEROCYCLIQUE-IMIDAZO°1,2-a!PYRIDINE-2- CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2932481B1 (fr) Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique.
FR2911605B1 (fr) Derives de pyrrolopyridine-2-carbowamides, leur preparation et leur application en therapeutique
FR2919610B1 (fr) Derives de n-heteroaryl-carboxamides tricycliques,leur preparation et leur application en therapeutique
FR2934594B1 (fr) Derives de thiophene-2-carboxamide, leur preparation et leur application en therapeutique.
FR2925903B1 (fr) DERIVES 6-HETEROCYCLIQUE-IMIDAZO°1,2-a!PYRIDINE-2- CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2930939B1 (fr) Derives de pyrrole, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 7

ST Notification of lapse

Effective date: 20170428